Author： Wong Nan Soon Morse Michael A
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.7, 2012-07, pp. : 1043-1055
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lonafarnib overcomes imatinib mesylate resistance
Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. :
Access to resources
Recommend
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. :
Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. :
By Reilly R.T. Machiels J-P.H. Jaffee E.M.
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 2, 2000-07 ,pp. :
By Nicholson S.
Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. :